Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
about
The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.Pregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through interaction with cell surface proteoglycansSyndecan-3 is a dendritic cell-specific attachment receptor for HIV-1Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionRole of heparan sulfate in sexually transmitted infectionsHIV Associated Neurocognitive DisordersHeparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T CellsM- and T-tropic HIVs promote apoptosis in rat neuronsDistinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 studyRegulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspasesInhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actin bundling, and cell migrationIncreased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection.Mouse models of neurological disorders: a view from the blood-brain barrier.Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systemsSyndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Human immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrierChondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo.The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcomeRole of the immune system in HIV-associated neuroinflammation and neurocognitive implications.The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Novel mechanisms of central nervous system damage in HIV infection.Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cellsThe HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.Heparan sulfate-dependent enhancement of henipavirus infection.Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update.Genetic variations in genes involved in heparan sulphate biosynthesis are associated with Plasmodium falciparum parasitaemia: a familial study in Burkina Faso.Transmembrane TNF-α Facilitates HIV-1 Infection of Podocytes Cultured from Children with HIV-Associated Nephropathy.When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?Glycoconjugate glycans as viral receptors.Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cellsHuman immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular diseaseOral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cellsgp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue.Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity.Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice.HIV-associated synaptic degeneration.A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.
P2860
Q24532969-C26F684F-F3B4-4F82-8684-152E238490FBQ24614349-D6D3DF4B-81EF-4BFA-8F4D-EF062A0D1C69Q24670055-BB4E26E4-9715-480E-A179-96E0542033B7Q27004059-3C51A2C3-E79C-4465-9430-00026F45458BQ27023959-8700E50E-FC6E-43C7-A052-250895EFC81FQ27023968-1E4C9D4D-36CD-4FC1-BAD6-56749E745850Q27472216-ED4DACE9-3798-475F-886D-922DB5B1EF50Q28572213-1A2A5E35-DABD-4CC5-AEE7-38F4732E15EDQ33395678-EB55C09C-7185-4F97-8D18-CA94B0331825Q33532625-1FAFE6B2-87C9-49AA-97A9-57A3A17EAE7DQ33707527-728B952F-D6AA-4C06-8441-2E97BC3A8AC9Q33897480-1E09D7BB-0C2C-4363-8837-0CC8D4079468Q33911116-44C1B113-E875-4A5D-8CD5-0C7E775737FDQ33930493-338323AF-7D36-4D4C-AB55-98FD3704F430Q33938994-32960FDA-45E4-4FF6-92DF-6482B08270B3Q33951943-7E912E50-30EB-4C36-982B-940E04AB1C40Q33962742-E366A532-F779-49E4-AD31-063C3EC891D4Q34326270-64498CE4-3957-450E-9E2E-A2AF0FFADD59Q34440312-18B84470-1EE2-439F-A04A-55C57D25CBE1Q34634294-5DEFE571-0648-427D-B01F-CD7BF5219408Q35125996-F889A28B-1767-4C50-8224-EB92EDD5B339Q35149334-E13EC997-F87E-4178-90DC-9A3F9926A2D6Q35177355-E6EEFE8D-1177-4A53-858A-C6CAF145B7DCQ35557261-E97277AD-ACA0-4426-8ECC-90CD5A8F8534Q35634313-78DD5005-EA1F-40B2-9D37-45C40A939A53Q35674470-8BD32DCA-3E59-4DA8-979B-CE157588F348Q35677600-0EE52EBC-D556-4472-B267-0F44C0AE98B5Q35708840-A05D9E77-B1F1-445B-9CD9-5F214167070CQ36000549-C1F2E1DD-EBAC-4190-9517-93A9844CDF52Q36181815-7A077001-D514-4EAB-95B3-EA77BFA6E528Q36188164-850EC27E-0DE3-4A8B-A1D7-1793F886505EQ36194868-7F7B6E00-B604-48FD-879C-E3D0D761B28AQ36373244-EC17C6B5-5CC8-4E40-A476-7FAEFCFD1177Q36512300-FB710542-C514-4A5C-AA91-BC1533866798Q36800904-6029A05F-57F8-489F-959B-CBCED7CD182AQ37333741-E3064FD8-DC21-4E36-9FFA-E3D8E1B8DD64Q38300914-662C1011-B4CD-41CE-BB62-C859D5504A7AQ38912920-C075051D-D4BA-400A-8A23-CE64BBF8CA14Q40066321-01B834CB-EC04-460D-811D-BAB92592E350Q40374556-B14F671D-E9C0-4B78-8AEC-391540B286B0
P2860
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@ast
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@en
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@nl
type
label
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@ast
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@en
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@nl
prefLabel
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@ast
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@en
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@nl
P2093
P2860
P1433
P1476
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
@en
P2093
Bernadette Van der Schueren
Dana Gabuzda
Didier Trono
Guido David
Jeffrey D Esko
Lianchun Wang
Michael D Bobardt
Milan Fiala
Patrick Salmon
Philippe A Gallay
P2860
P304
P356
10.1128/JVI.78.12.6567-6584.2004
P407
P577
2004-06-01T00:00:00Z